Order of the Supreme Court of India in the matter of Network of People Living With HIV/AIDS & Others Vs Union of India & Others dated 24/02/2025. The Supreme Court (SC), February 24, 2025 has directed all states to file their affidavits addressing concerns raised about antiretroviral therapy (ART) drugs …
Despite clinical trials coming under scrutiny, nothing much has changed on ground as many irregularities continue to exist. While the office of the Drugs Controller General of India (DCGI) is still struggling to accumulate data, compensation had been paid only in 50 per cent of the clinical trial death cases …
In an evaluation of medicines approved by the European Medicines Agency 2000 to 2010, Ruben Duijnhoven and colleagues find that the number of patients evaluated for medicines approved for chronic use are inadequate for evaluation of safety or long-term efficacy.
Taking suo motu cognisance of a letter seeking action against renowned pharmaceutical companies for looting cancer patients by printing inflated maximum retail price (MRP) on medicines, the Punjab and Haryana High Court today put the state of Punjab on notice. The Division Bench of Chief Justice Arjan Kumar Sikri and …
Agovernment panel has proposed that prices of patented medicines be based on the country’s per capita income, a move that would substantially reduce prices of costly drugs made by global pharmaceutical firms. The proposal, which seeks the input of other government agencies as well as industry groups, could provoke the …
New Delhi: The death of a student in UK reportedly due to weight-loss pills has led to serious concerns about substance abuse. Doctors say the practice is common among youngsters in India too. Weight-loss pills, which act by altering appetite, metabolism or absorption of nutrients, are available over the counter …
INDORE: Madhya Pradesh Scheduled Caste Commission chairman, Narayanprasad Kabirpanthi on Sunday heard nearly seven complaints related to atrocities on people from backward classes. While hearing the complaints of the victims of clinical trials, Kabirpanthi announced to constitute a bench of commission, which will hear case by case complaint of clinical …
Panels meant to ensure safety & rights of volunteers must be registered with DCGI Starting next week, all ethics panels that are meant to ensure the safety and rights of volunteers for clinical trials, must be registered with the Drug Controller General of India. The changes in the norms for …
New tools for malaria control, artemisinin combination therapy (ACT) and long-lasting insecticidal nets (LLINs) were recently introduced across India. We estimated the impact of universal coverage of ACT and ACT plus LLINs in a setting of hyperendemic, forest malaria transmission.
Forms four expert panels to draft permission guidelines Following more than 2,200 deaths in clinical trials in the past five years, the government has finally set up four expert committees to streamline approvals and evolve standard operating procedures for marketing of drugs in India, which are discovered abroad. The move …
K. Srinath Reddy and Ambuj Roy discuss the Research Article by Patricia McGettigan and David Henry about the continued use of NSAIDs associated with increased risk of cardiovascular disease, including the mechanisms of increased risk, probable reasons for ongoing use, and next steps.
Patricia McGettigan and David Henry find that, although some non-steroidal anti-inflammatory drugs (NSAIDs) such as diclofenac are known to increase cardiovascular risk, diclofenac is included on 74 countries essential medicine lists and was the most commonly used NSAID in the 15 countries they evaluated. Original Source
The National Human Rights Commission (NHRC) on Thursday issued a notice to the Union health secretary on a complaint alleging that three big government hospitals in Delhi conducted illegal clinical drug trials on 3,479 children during the last five years. The commission’s notice cited illegal clinical trials allegedly conducted on …
The rules notified by the government for compensating clinical trial victims have failed to address the concerns raised by patient groups and health activists. The norms, which have come into place after repeated slamming of the government by the Supreme Court, do not specify any quantum of compensation that pharmaceutical …
The National Human Rights Commission (NHRC) on Thursday issued a notice to the Union Health Ministry after receiving information that three government hospitals committed illegal drug trials on nearly 3,500 children in the past five years. According to NHRC, a notice was sent to the Secretary of Union Ministry of …
The National Human Rights Commission (NHRC) on Thursday issued a notice to the Union Health Ministry after receiving information that three government hospitals committed illegal drug trials on nearly 3,500 children in the past five years. According to NHRC, a notice was sent to the Secretary of Union Ministry of …
Xpert, the quick test for tuberculosis already endorsed by WHO, has been found accurate for TB including drug-resistant strains, according to a new study publsihed in The Cochrane Library. WHO in 2010 endorsed the two-hour, molecular diagnostic TB test, which requires little skilled expertise. With the cost of the test …
Some 40 drugs will soon be notified under a new schedule, H1, of Drugs and Cosmetics Act to make it mandatory for chemists to maintain a register of their sales and retain a copy of the prescription. This will be in addition to the schedule H drugs which, too, can't …
Issuing licence is totally compliant with multilateral agreements: Sharma India, on Wednesday, conveyed to the U.S. that it had not violated any multilateral trade agreement by issuing compulsory licence for Bayer’s patented anti-cancer drug Nexavar to a local firm so as to make it affordable. It also asserted that such …
Realising the urgency for the industry to take a pro-active stance to create patient awareness and education about clinical research, The Association of Biotechnology Led Enterprises (ABLE) is planning to set up a clinical trials committee. This move is to assist the government and the industry to share information arising …
